CEO Bob Bradway rallies the manufacturing team at Amgen Ohio with a chant of “OH-IO.”
Earlier this year, NVIDIA and Amgen revealed plans to analyze one of the world’s largest human datasets using AI models trained on an NVIDIA DGX SuperPOD in Iceland. Now, Amgen is signaling its continued commitment to cutting-edge tech with a ribbon cutting for an advanced biomanufacturing facility in New Albany, Ohio.
Known as Amgen Ohio, the facility is designed to uphold the company’s reputation for quality and reliability. It will play a significant role in producing innovative biomedicines to address serious diseases, employing approximately 400 people across various roles.
The new facility “was designed with the latest innovation and technology to deliver safe, reliable medicines for ‘every patient, every time,’” said Bob Bradway, chairman and chief executive officer at Amgen.
Amge…